Study in NSCLC: is Timely Analysis of EGFR-mutation Status Feasible in Region Antwerp, Belgium.
NCT01260038
·
clinicaltrials.gov ↗
COMPLETED
Status
107
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Sponsor
University Hospital, Antwerp
Collaborators
[object Object]
[object Object]